Today

Agents

Chat

Arena

Discover

More

App

Zymeworks to report Q2 results after market close - ZYME News | Rallies

Zymeworks to report Q2 results after market close

ZYME•2026-07-16

No earnings call planned

The company said no Q2 earnings conference call is planned due to the proposed Theravance Biopharma acquisition.

Q2 results scheduled for Aug. 6

Zymeworks said it will release its Q2 2026 financial results on Aug. 6, 2026, after the market close.

Related News

BlackRock <BLK.N>: Deutsche Bank raises target price to $1258 from $1232

BLK•2026-07-16

Morgan Stanley <MS.N>: Wells Fargo raises target price to $240 from $225

MS•2026-07-16

ESAB schedules Q2 earnings release, conference call

2026-07-16

Goldman Sachs <GS.N>: BofA Global Research raises price objective to $1,300.00 from $1,150.00

GS•2026-07-16

Blackstone Secured Lending schedules Q2 earnings webcast and conference call

BXSL•2026-07-16